Juan R. Luciano
Known title: DirectorCIK: 0001455792
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ADM Faces Q3 Earnings and Sweetener Market Weakness. Archer-Daniels-Midland is approaching its Q3 2026 earnings report amid concerns about weakness in its sweetener business. Analysts are debating whether performance in the ethanol sector can offset these headwinds. The company’s dividend reliability remains a key focus for investors, though cyclical uncertainty persists.
Transaction History
| LLY | ▲ Buy | Grant | 14 | $16K | 9/21/2026 | View on chart |
| LLY | ▲ Buy | Grant | 13 | $16K | 8/17/2026 | View on chart |
| LLY | ▲ Buy | Grant | 14 | $16K | 7/20/2026 | View on chart |
| LLY | ▲ Buy | Grant | 14 | $16K | 6/15/2026 | View on chart |
| LLY | ▲ Buy | Grant | 16 | $16K | 5/18/2026 | View on chart |
| LLY | ▲ Buy | Grant | 17 | $16K | 4/20/2026 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 16,882 | $1.2M | 3/20/2026 | View on chart |
| LLY | ▲ Buy | Grant | 16 | $16K | 3/16/2026 | View on chart |
| LLY | ▲ Buy | Grant | 15 | $16K | 2/17/2026 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 23,330 | $1.6M | 2/13/2026 | View on chart |
| ADM | ▲ Buy | Grant | 106,475 | $0 | 2/12/2026 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 12,842 | $852K | 2/9/2026 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 36,249 | $2.4M | 2/9/2026 | View on chart |
| ADM | ▲ Buy | Option Exercise | 581,099 | $19.3M | 2/5/2026 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 414,728 | $27.9M | 2/5/2026 | View on chart |
| ADM | ▲ Buy | Grant | 81,825 | $0 | 2/4/2026 | View on chart |
| LLY | ▲ Buy | Grant | 15 | $16K | 1/20/2026 | View on chart |
| LLY | ▲ Buy | Grant | 14 | $15K | 12/15/2025 | View on chart |
| LLY | ▲ Buy | Grant | 215 | $220K | 11/17/2025 | View on chart |
| LLY | ▲ Buy | Grant | 15 | $15K | 11/17/2025 | View on chart |
| LLY | ▲ Buy | Grant | 18 | $15K | 10/20/2025 | View on chart |
| LLY | ▲ Buy | Grant | 20 | $15K | 9/15/2025 | View on chart |
| LLY | ▲ Buy | Grant | 21 | $15K | 8/18/2025 | View on chart |
| LLY | ▲ Buy | Grant | 19 | $15K | 7/21/2025 | View on chart |
| LLY | ▲ Buy | Grant | 18 | $15K | 6/16/2025 | View on chart |
| LLY | ▲ Buy | Grant | 20 | $15K | 5/19/2025 | View on chart |
| LLY | ▲ Buy | Grant | 18 | $15K | 4/21/2025 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 17,394 | $816K | 3/20/2025 | View on chart |
| LLY | ▲ Buy | Grant | 18 | $15K | 3/17/2025 | View on chart |
| LLY | ▲ Buy | Grant | 17 | $15K | 2/18/2025 | View on chart |
| ADM | ▲ Buy | Grant | 154,890 | $0 | 2/13/2025 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 12,897 | $590K | 2/10/2025 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 34,145 | $1.6M | 2/10/2025 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 40,648 | $1.9M | 2/10/2025 | View on chart |
| ADM | ▲ Buy | Grant | 77,076 | $0 | 2/7/2025 | View on chart |
| LLY | ▲ Buy | Grant | 20 | $15K | 1/21/2025 | View on chart |
| LLY | ▲ Buy | Grant | 19 | $15K | 12/16/2024 | View on chart |
| LLY | ▲ Buy | Grant | 20 | $15K | 11/18/2024 | View on chart |
| LLY | ▲ Buy | Grant | 303 | $220K | 11/18/2024 | View on chart |
| LLY | ▲ Buy | Grant | 16 | $14K | 10/21/2024 | View on chart |
| LLY | ▲ Buy | Grant | 16 | $15K | 9/16/2024 | View on chart |
| ADM | ▲ Buy | Option Exercise | 170,194 | $8.0M | 9/3/2024 | View on chart |
| ADM | ▼ Sell | Open Market | 170,194 | $10.3M | 9/3/2024 | View on chart |
| ADM | ▲ Buy | Option Exercise | 45,471 | $2.1M | 8/30/2024 | View on chart |
| ADM | ▼ Sell | Open Market | 45,471 | $2.8M | 8/30/2024 | View on chart |
| ADM | ▲ Buy | Option Exercise | 99,752 | $4.7M | 8/29/2024 | View on chart |
| ADM | ▼ Sell | Open Market | 99,752 | $6.1M | 8/29/2024 | View on chart |
| ADM | ▲ Buy | Option Exercise | 3,683 | $173K | 8/28/2024 | View on chart |
| ADM | ▼ Sell | Open Market | 3,683 | $225K | 8/28/2024 | View on chart |
| ADM | ▲ Buy | Option Exercise | 5,721 | $268K | 8/26/2024 | View on chart |
| ADM | ▼ Sell | Open Market | 5,721 | $349K | 8/26/2024 | View on chart |
| LLY | ▲ Buy | Grant | 16 | $15K | 8/19/2024 | View on chart |
| LLY | ▲ Buy | Grant | 16 | $15K | 7/15/2024 | View on chart |
| LLY | ▲ Buy | Grant | 17 | $15K | 6/17/2024 | View on chart |
| ADM | ▼ Sell | Gift | 182,501 | $0 | 5/28/2024 | View on chart |
| ADM | ▼ Sell | Gift | 182,501 | $0 | 5/28/2024 | View on chart |
| LLY | ▲ Buy | Grant | 19 | $15K | 5/20/2024 | View on chart |
| LLY | ▲ Buy | Grant | 20 | $15K | 4/15/2024 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 64,830 | $3.8M | 3/21/2024 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 10,390 | $548K | 3/20/2024 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 64,830 | $3.4M | 3/20/2024 | View on chart |
| ADM | ▲ Buy | Grant | 115,479 | $0 | 3/20/2024 | View on chart |
| LLY | ▲ Buy | Grant | 19 | $14K | 3/18/2024 | View on chart |
| ADM | ▲ Buy | Grant | 146,342 | $0 | 3/18/2024 | View on chart |
| LLY | ▲ Buy | Grant | 20 | $15K | 2/20/2024 | View on chart |
| LLY | ▲ Buy | Grant | 23 | $15K | 1/16/2024 | View on chart |
| LLY | ▲ Buy | Grant | 25 | $14K | 12/18/2023 | View on chart |
| LLY | ▲ Buy | Grant | 24 | $14K | 11/20/2023 | View on chart |
| LLY | ▲ Buy | Grant | 335 | $200K | 11/20/2023 | View on chart |
| LLY | ▲ Buy | Grant | 23 | $14K | 10/16/2023 | View on chart |
| LLY | ▲ Buy | Grant | 25 | $14K | 9/18/2023 | View on chart |
| LLY | ▲ Buy | Grant | 26 | $14K | 8/21/2023 | View on chart |
| LLY | ▲ Buy | Grant | 32 | $14K | 7/17/2023 | View on chart |
| LLY | ▲ Buy | Grant | 32 | $14K | 6/20/2023 | View on chart |
| LLY | ▲ Buy | Grant | 33 | $14K | 5/15/2023 | View on chart |
| LLY | ▲ Buy | Grant | 39 | $15K | 4/17/2023 | View on chart |
| LLY | ▲ Buy | Grant | 43 | $14K | 3/20/2023 | View on chart |
| ADM | ▼ Sell | Gift | 291,999 | $0 | 3/2/2023 | View on chart |
| ADM | ▼ Sell | Gift | 291,999 | $0 | 3/2/2023 | View on chart |
| LLY | ▲ Buy | Grant | 44 | $14K | 2/21/2023 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 232,233 | $19.1M | 2/13/2023 | View on chart |
| ADM | ▲ Buy | Grant | 87,842 | $0 | 2/9/2023 | View on chart |
| ADM | ▲ Buy | Grant | 349,488 | $0 | 1/25/2023 | View on chart |
| LLY | ▲ Buy | Grant | 40 | $14K | 1/17/2023 | View on chart |
| LLY | ▲ Buy | Grant | 39 | $14K | 12/19/2022 | View on chart |
| LLY | ▲ Buy | Grant | 39 | $14K | 11/21/2022 | View on chart |
| LLY | ▲ Buy | Grant | 498 | $180K | 11/21/2022 | View on chart |
| ADM | ▲ Buy | Option Exercise | 300,000 | $10.0M | 10/26/2022 | View on chart |
| ADM | ▼ Sell | Open Market | 190,374 | $17.7M | 10/26/2022 | View on chart |
| ADM | ▼ Sell | Open Market | 109,626 | $10.3M | 10/26/2022 | View on chart |
| LLY | ▲ Buy | Grant | 42 | $14K | 10/17/2022 | View on chart |
| LLY | ▲ Buy | Grant | 46 | $14K | 9/19/2022 | View on chart |
| ADM | ▲ Buy | Option Exercise | 234,531 | $9.5M | 9/9/2022 | View on chart |
| ADM | ▲ Buy | Option Exercise | 50,000 | $1.7M | 9/9/2022 | View on chart |
| ADM | ▼ Sell | Open Market | 14,089 | $1.3M | 9/9/2022 | View on chart |
| ADM | ▼ Sell | Open Market | 35,911 | $3.3M | 9/9/2022 | View on chart |
| ADM | ▼ Sell | Open Market | 67,243 | $6.2M | 9/9/2022 | View on chart |
| ADM | ▼ Sell | Open Market | 167,288 | $15.2M | 9/9/2022 | View on chart |
| LLY | ▲ Buy | Grant | 45 | $14K | 8/15/2022 | View on chart |
| LLY | ▲ Buy | Grant | 44 | $14K | 7/18/2022 | View on chart |
| LLY | ▲ Buy | Grant | 47 | $14K | 6/21/2022 | View on chart |
| ADM | ▼ Sell | Gift | 242,728 | $0 | 6/7/2022 | View on chart |
| ADM | ▼ Sell | Gift | 242,728 | $0 | 6/7/2022 | View on chart |
| LLY | ▲ Buy | Grant | 47 | $14K | 5/16/2022 | View on chart |
| LLY | ▲ Buy | Grant | 42 | $13K | 4/18/2022 | View on chart |
| LLY | ▲ Buy | Grant | 43 | $12K | 3/21/2022 | View on chart |
| LLY | ▲ Buy | Grant | 53 | $13K | 2/22/2022 | View on chart |
| ADM | ▼ Sell | Tax Withholding | 193,051 | $14.8M | 2/14/2022 | View on chart |
| ADM | ▲ Buy | Grant | 91,756 | $0 | 2/10/2022 | View on chart |
| ADM | ▲ Buy | Grant | 272,871 | $0 | 2/2/2022 | View on chart |
| ADM | ▲ Buy | Option Exercise | 216,585 | $5.7M | 1/31/2022 | View on chart |
| ADM | ▲ Buy | Option Exercise | 51,664 | $1.7M | 1/31/2022 | View on chart |
| ADM | ▼ Sell | Open Market | 24,388 | $1.8M | 1/31/2022 | View on chart |
| ADM | ▼ Sell | Open Market | 27,276 | $2.0M | 1/31/2022 | View on chart |
| ADM | ▼ Sell | Open Market | 97,147 | $7.2M | 1/31/2022 | View on chart |
| ADM | ▼ Sell | Open Market | 119,438 | $8.9M | 1/31/2022 | View on chart |
| LLY | ▲ Buy | Grant | 51 | $13K | 1/18/2022 | View on chart |
| LLY | ▲ Buy | Grant | 677 | $175K | 11/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Eli Lilly gets EMA backing for Foundayo obesity pill
The European Medicines Agency panel issued a positive opinion on Lilly's Foundayo pill for obesity and type 2 diabetes, clearing a regulatory hurdle for the drug. Recent coverage also notes Lilly's broader pipeline beyond Zepbound and rising competitive pressure on Novo Nordisk. In parallel, the company's largest shareholder announced a $347 million stock sale, adding another layer of market interest.
Eli Lilly gets EMA backing for Foundayo obesity pill. The European Medicines Agency panel issued a positive opinion on Lilly's Foundayo pill for obesity and type 2 diabetes, clearing a regulatory hurdle for the drug. Recent coverage also notes Lilly's broader pipeline beyond Zepbound and rising competitive pressure on Novo Nordisk. In parallel, the company's largest shareholder announced a $347 million stock sale, adding another layer of market interest.